Christopher Charles DeRenzo MD
Pediatric Solid Tumor Oncology
Assistant Member, Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital
Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3300
Dr. DeRenzo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
TN State Medical License 2018 - 2025
TX State Medical License 2014 - 2020
OH State Medical License 2008 - 2012
UT State Medical License 2011 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 10 citationsEpigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy.Tae Gun Kang, Xin Lan, Tian Mi, Hongfeng Chen, Shanta Alli
Science. 2024-10-11 - Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models.Lindsay J Talbot, Ashley Chabot, Aaron B Ross, Alexandra Beckett, Phuong Nguyen
Clinical Cancer Research. 2024-10-01 - 19 citationsAutologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber
Nature Cancer. 2024-06-01
Press Mentions
Improved CAR T Cell Homing Increases Efficacy of Osteosarcoma TreatmentAugust 8th, 2024
Improved Chemokine Homing Enhances CAR T--Cell Therapy for OsteosarcomaAugust 8th, 2024
Improved Chemokine Homing Enhances CAR T-cell Therapy in Preclinicals for OsteosarcomaAugust 8th, 2024
Grant Support
- Enhancing B7-H3-CAR T cell therapy for pediatric solid tumorsST. JUDE CHILDREN'S RESEARCH HOSPITAL2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
